Status:
RECRUITING
Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk
Lead Sponsor:
Mayo Clinic
Conditions:
Breast Carcinoma
Eligibility:
FEMALE
18-100 years
Brief Summary
The purpose of this research is to better understand how benign breast diseases might lead to breast cancer, focusing on genetic factors and including a diverse range of participants to improve future...
Eligibility Criteria
Inclusion
- Female patients, ages 18 to 100 years
- Had a benign breast biopsy at Mayo Clinic between 2002-2022
Exclusion
- All male patients
- Prior or concomitant diagnosis of BC
- Diagnosis of BC within six months of benign breast disease
- Denial of research authorization
- Concurrent or post-biopsy bilateral prophylactic mastectomy
Key Trial Info
Start Date :
August 28 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2030
Estimated Enrollment :
4500 Patients enrolled
Trial Details
Trial ID
NCT07207564
Start Date
August 28 2025
End Date
June 30 2030
Last Update
October 10 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Florida
Jacksonville, Florida, United States, 32224-9980
2
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905